Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study

NCT05897697 | Completed

• 1 other identifier: UGeneva 2021-01336
• Study Type: observational
• Target: 122
• Locations: 2 countries
• Sites: 2

Brief Summary

The preferences of pregnant women for postpartum thromboprophylaxis are largely unknown. The aims of this transversal study are to elicit the preferences of pregnant/postpartum women about postpartum thromboprophylaxis in semi-structured interviews, and to estimate the utility of the relevant health states (pulmonary embolism, deep vein thrombosis, postpartum hemorrhage, subcutaneous injections). In this second aim, the investigators will also compare the effect of 2 different techniques to estimate utilities (standard gamble vs. time trade-off), using a randomization of these techniques.

Conditions

Venous Thromboembolism; Pregnancy Related

Outcome Measures

Primary Outcomes (2)

• Preference for postpartum thromboprophylaxis

  Risk of postpartum venous thromboembolism at which thromboprophylaxis is preferred

  90 days of delivery

• Quality-of-life of pulmonary embolism, deep vein thrombosis, postpartum hemorrhage and subcutaneous injections

  Measurements of utilities of pulmonary embolism, deep vein thrombosis, postpartum hemorrhage and subcutaneous injections, by standard gamble and time trade-off methods

  90 days of delivery

Study Arms (1)

Pregnant / postpartum women

Adult women during pregnancy or the early postpartum period (within 7 days of delivery)

Other: Interview

Interventions

Interview OTHER

Structured interview

Pregnant / postpartum women

Eligibility Criteria

• Age: 18 Years+
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Adult women in a current pregnancy or within 7 days of delivery.

You may qualify if:

• women
• ongoing pregnancy or within 7 days of delivery
• fluency in French or English

You may not qualify if:

• fetal or neonatal death

Sponsors & Collaborators

• Marc Blondon: lead

Study Sites (2)

Justine Hugon-Rodin

Paris, France

Location

Marc Blondon

Geneva, 1205, Switzerland

Location

MeSH Terms

Conditions

Venous Thromboembolism

Interventions

Interviews as Topic

Condition Hierarchy (Ancestors)

Thromboembolism; Embolism and Thrombosis; Vascular Diseases; Cardiovascular Diseases

Intervention Hierarchy (Ancestors)

Data Collection; Epidemiologic Methods; Investigative Techniques; Health Care Evaluation Mechanisms; Quality of Health Care; Health Care Quality, Access, and Evaluation; Public Health; Environment and Public Health

Study Design

• Study Type: observational
• Observational Model: OTHER
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR INVESTIGATOR
• PI Title: Principal Investigator

Study Record Dates

• First Submitted: June 1, 2023
• First Posted: June 9, 2023
• Study Start: September 24, 2021
• Primary Completion: October 7, 2022
• Study Completion: October 7, 2022
• Last Updated: June 12, 2023

Record last verified: 2023-06

Data Sharing

• IPD Sharing: Will not share

Locations

CH (1); FR (1)